Achieve Life Sciences, Inc. (ACHV)
4.455
-0.32
(-6.60%)
USD |
NASDAQ |
May 19, 16:00
4.455
0.00 (0.00%)
After-Hours: 18:18
Achieve Life Sciences Research and Development Expense (Quarterly) : 3.292M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 7.47M |
| Edesa Biotech, Inc. | 2.767M |
| Xenon Pharmaceuticals, Inc. | 87.92M |
| ProMIS Neurosciences, Inc. | 6.971M |
| Medicus Pharma Ltd. | 1.972M |